Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference

On December 29, 2025 Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, reported that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026, at 9:45 a.m. Pacific Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at View Source A replay of the webcast will be available for 30 days following the conclusion of the live broadcast.

(Press release, Veracyte, DEC 29, 2025, View Source [SID1234661641])